Literature DB >> 10455425

Insulation of a conditionally expressed transgene in an adenoviral vector.

G Vassaux1, H C Hurst, N R Lemoine.   

Abstract

Replication-defective recombinant adenoviruses provide an efficient system for in vivo gene transfer and numerous studies have demonstrated that this vector can accommodate tissue-specific promoters to restrict the expression of a transgene to a particular subset of cells. However, in some cases the selectivity of expression is lost when the tissue-specific promoter is placed in an adenoviral environment. In an attempt to restore the conditionality of expression of the transgene driven by the human ERBB2 promoter, we have flanked the expression cassette in 5' and 3' orientations with a 250 bp sequence containing the bovine growth hormone transcriptional stop signal for cloning into a recombinant adenovirus. The data presented here clearly demonstrate that these 'insulator' elements are able to restrict the expression of the transgene (herpes simplex thymidine kinase) to ERBB2-expressing cells and therefore to restore the selectivity mediated by the ERBB2 promoter. This approach could be generally useful to insulate expression cassettes in adenoviral vectors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455425     DOI: 10.1038/sj.gt.3300910

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  11 in total

1.  Transcription initiation activity of adenovirus left-end sequence in adenovirus vectors with e1 deleted.

Authors:  Masato Yamamoto; Julia Davydova; Koichi Takayama; Ramon Alemany; David T Curiel
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element.

Authors:  R P Haberman; T J McCown; R J Samulski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Adenoviral insulinoma-associated protein 1 promoter-driven suicide gene therapy with enhanced selectivity for treatment of neuroendocrine cancers.

Authors:  Victoria Akerstrom; Chiachen Chen; Michael S Lan; Mary B Breslin
Journal:  Ochsner J       Date:  2013

Review 4.  Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer.

Authors:  Dirk M Nettelbeck
Journal:  J Mol Med (Berl)       Date:  2007-12-19       Impact factor: 4.599

5.  Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.

Authors:  Guan Jiang; Chao Sun; Rong-Hua Li; Zhi-Ping Wei; Jun-Nian Zheng; Yan-Qun Liu
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-08       Impact factor: 4.553

6.  Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma.

Authors:  Kang-Jian Zhang; Jing Qian; Shi-Bing Wang; Yi Yang
Journal:  J Biomed Sci       Date:  2012-02-09       Impact factor: 8.410

7.  Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.

Authors:  Dennis Hoffmann; Oliver Wildner
Journal:  BMC Biotechnol       Date:  2006-08-03       Impact factor: 2.563

Review 8.  Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment.

Authors:  H C Hurst
Journal:  Breast Cancer Res       Date:  2001-10-01       Impact factor: 6.466

Review 9.  Gene therapy for carcinoma of the breast: Genetic toxins.

Authors:  G Vassaux; N R Lemoine
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

10.  Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors.

Authors:  Inge Peerlinck; Saeid Amini-Nik; Robin K Phillips; Richard Iggo; Nicholas R Lemoine; Sabine Tejpar; Georges Vassaux
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.